CHI3L1 and Alzheimer disease: When subsequently adjusting the group comparisons using age as a covariant, increased levels of YKL-40 were found in AD patients compared to all other patient groups and non-demented controls (ANCOVA F ratio 6.8535, p = 0.0002).